Template:ICD-11 Viral infection table: Difference between revisions
From Embryology
mNo edit summary |
mNo edit summary |
||
Line 12: | Line 12: | ||
* {{ICD11weblink}}453730080 KA62.6 Congenital human immunodeficiency virus infection] - ''A disease affecting neonates, caused by an infection with human immunodeficiency virus in utero. Transmission is by vertical transmission. Confirmation is by identification of human immunodeficiency virus in the neonate.'' | * {{ICD11weblink}}453730080 KA62.6 Congenital human immunodeficiency virus infection] - ''A disease affecting neonates, caused by an infection with human immunodeficiency virus in utero. Transmission is by vertical transmission. Confirmation is by identification of human immunodeficiency virus in the neonate.'' | ||
* {{ICD11weblink}}648536096 KA62.7 Congenital parvovirus syndrome] - ''Fetal parvovirus syndrome is a fetopathy likely to occur when a pregnant woman is infected by parvovirus B19. Fetal parvovirus infection results in aplastic crisis. Anaemia induces a risk of hydrops and fetal death by cardiac failure in 10 to 20% of cases.'' | * {{ICD11weblink}}648536096 KA62.7 Congenital parvovirus syndrome] - ''Fetal parvovirus syndrome is a fetopathy likely to occur when a pregnant woman is infected by parvovirus B19. Fetal parvovirus infection results in aplastic crisis. Anaemia induces a risk of hydrops and fetal death by cardiac failure in 10 to 20% of cases.'' | ||
* {{ICD11weblink}}1059053724 KA62.8 | * {{ICD11weblink}}1059053724 KA62.8 Congenital rubella syndrome] - ''A disease caused by an infection with the rubella virus in utero. This disease presents with symptoms depending on the timing of infection of the fetus and may present with birth defects (such as hearing loss), or intrauterine growth retardation. Transmission is by vertical transmission. Confirmation is by identification of rubella virus or detection of anti-rubella virus IgM antibodies in the neonate or infant.'' | ||
* {{ICD11weblink}}1270001765 KA62.9 Congenital viral hepatitis] - ''A disease of the liver affecting the neonate, caused by an infection with either hepatitis A, B, C, D, or E virus in utero. This disease is characterized by lethargy, jaundice, abdominal distention, failure to thrive, or clay coloured stools. Transmission is by vertical transmission. Confirmation is by identification of the hepatitis A, B, C, D, or E virus in a blood sample from the neonate.'' | * {{ICD11weblink}}1270001765 KA62.9 Congenital viral hepatitis] - ''A disease of the liver affecting the neonate, caused by an infection with either hepatitis A, B, C, D, or E virus in utero. This disease is characterized by lethargy, jaundice, abdominal distention, failure to thrive, or clay coloured stools. Transmission is by vertical transmission. Confirmation is by identification of the hepatitis A, B, C, D, or E virus in a blood sample from the neonate.'' | ||
* {{ICD11weblink}}788102641 KA62.A Perinatal Herpes simplex infection] - ''Herpes simplex infection acquired during the perinatal period, normally from active herpes infection of the mother's genital tract, but may also be transmitted in utero.'' | * {{ICD11weblink}}788102641 KA62.A Perinatal Herpes simplex infection] - ''Herpes simplex infection acquired during the perinatal period, normally from active herpes infection of the mother's genital tract, but may also be transmitted in utero.'' |
Latest revision as of 10:14, 14 April 2019
ICD-11 KA62 Viral infection in the foetus or newborn |
---|
Any condition affecting foetuses or newborns, caused by an infection with a virus.
|
viral infection | environmental abnormalities | ICD-11 | Infections of the foetus or newborn |